Analysis and Characterization of Trauma-Induced Coagulopathy

描述（由申请人提供）：不受控制的出血是暴露于严重创伤的成年人死亡的主要原因。创伤性凝血病（TIC）发生在损伤和休克后，伴随着炎症和凝血事件的“风暴”，导致止血过程丧失能力。tic损害止血系统，因为在全体性基础上发生的过程失调，其中蛋白质水解系统破坏了必需的凝血成分。先前的研究已经确定了活化的蛋白c介导的辅助因子Va的破坏，并涉及全身纤维蛋白溶解活性，其中不受调节的蛋白溶解破坏纤维蛋白原和部分血浆凝固系统。在TIC患者的放血中观察到的这些终末事件是由血液和血管组织中的蛋白质、细胞和细胞因子以及进入血液的组织损伤物质的体内过程引起的。抽搐的原因和广度尚不清楚。该策略提案提供了血浆蛋白、血细胞、血管内皮、血管和血管外组织对TIC的贡献的综合评估，利用了一个独特的基础设施，包括已经资助的涉及创伤试验和系统生物学的国防部站点。由凝血和炎症研究的主要研究人员组成的综合团队方法使用体外和体内方法的复合方法来确定负责tic的候选药物来解决问题。5个战术创伤中心将使实验室结果早期转化为有用的技术成为可能。在进行这些研究的同时，将发展与参与国防部临床试验的临床中心的互动，其中每个中心的研究人员将负责护理点研究和血液样本的处理。收集技术将利用抑制鸡尾酒来阻止体外，静脉切开术后的伪影。血液/血浆样本将被运送到一个安全的仓库，并利用新技术进行分析，以确定TIC事件的自然历史。战术研究项目的继续将取决于它们对创伤患者的诊断和治疗选择的潜在效用。虽然不受控制的出血是严重创伤患者死亡的主要原因，但这种出血的原因尚不完全清楚。我们计划全面描述创伤相关凝血和出血的原因，并提出诊断不同原因的方法和最终的治疗干预措施，以防止创伤环境中的发病率和死亡率。

DESCRIPTION (provided by applicant): Uncontrolled hemorrhage is the major cause of death in adults exposed to severe trauma. Trauma induced coagulopathy (TIC) occurs after injury and shock, accompanied by a "storm" of inflammatory and coagulation events leading to incapacitation of the hemostatic process. TICs compromise the hemostatic system because of dysregulated processes occurring on a systemic basis in which proteolytic systems destroy essential coagulation components. Previous studies have identified activated protein C-mediated destruction of the cofactor factor Va and implicated systemic fibrinolytic activity in which unregulated proteolysis destroys fibrinogen and parts of the plasma coagulation system. These terminal events observed in phlebotomy blood of TIC patients are caused by in vivo processes involving the proteins, cells and cytokines in blood and vascular tissues and tissue damage material entering the blood. The causes and breadth of TICs are not understood. This TACTIC proposal provides a comprehensive evaluation of the contributions of plasma proteins, blood cells, the vascular endothelium, the blood vessel, and extravascular tissue to TIC, making use of a unique infrastructure that includes already-funded DoD sites involved in trauma trials and Systems Biology. A comprehensive team approach by leading investigators in coagulation and inflammation research addresses the problem using a composite of in vitro and in vivo approaches to identify candidates responsible for TICs. Early translation of laboratory results into useful technology will be enabled by a set of 5 TACTIC trauma centers. Simultaneous with these studies, interactions with clinical centers engaged in DoD clinical trials will be developed in which research personnel at each center will be responsible for point-of-care studies and processing of blood samples. Collection techniques will utilize inhibitory cocktails to block ex vivo, post phlebotomy artifacts. Blood/plasma samples will be shipped to a secure repository and analyzed utilizing new technology to identify the natural history of TIC events. Continuation of TACTIC research projects will be dependent upon their potential utility for diagnosis and selection of therapy for trauma patients. Although uncontrolled bleeding is the major cause of death in people with severe traumatic injuries, the reasons for this bleeding are not completely understood. We plan to comprehensively describe the causes of trauma-related clotting and bleeding, and propose methods to diagnose the different causes and ultimately therapeutic interventions to prevent morbidity and mortality in traumatic settings.